-transparent.png){kind=logo}
Thirty-eight patients with virologically proven dendritic keratitis were treated using either debridement plus human leukocyte interferon (HLI) or debridement plus human fibroblast interferon (HFI) in a randomized, double-blind study. We administered one drop of HLI or HFI (1 X 10(6) reference units/ml) daily and found no significant difference in the action of either type of interferon.
Related Publications
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
March 1983,
American journal of ophthalmology,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
January 1977,
Bericht uber die Zusammenkunft. Deutsche Ophthalmologische Gesellschaft,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
August 1982,
The British journal of ophthalmology,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
December 1983,
Archives of ophthalmology (Chicago, Ill. : 1960),
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
January 1987,
Current eye research,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
November 1973,
Harefuah,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
January 1980,
Journal of clinical microbiology,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
January 1987,
Journal of ocular pharmacology,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
January 1989,
Clinical therapeutics,
R Sundmacher, and
K Cantell, and
R Skoda, and
C Hallermann, and
D Neumann-Haefelin
September 1965,
Southern medical journal,
